Researchers at the Indira Gandhi Agricultural University in Raipur, Chhattisgarh, have discovered that a specific variety of rice, known as ‘Sanjeevani,’ can potentially eliminate cancer cells. This rice, originating from a nearly extinct variety in Bastar, has shown promising results in laboratory tests, raising hopes for a non-invasive cancer treatment. Experiments at the Bhabha Atomic Research Centre on mice yielded positive outcomes, and the Central Drug Research Institute has also confirmed the cancer-fighting properties of Sanjeevani rice. Human trials are scheduled to commence in January at the Tata Memorial Cancer Hospital. The rice contains 213 biochemicals, including seven compounds known for their anti-cancer effects, which activate Nrf2, an antioxidant that combats oxidative damage that can lead to cancer. The rice could potentially be used in a treatment regimen where one consumes 10 grams of the rice daily. The rice is said to boost immunity. This marks a significant breakthrough, potentially making Sanjeevani rice the world’s first rice variety with medicinal applications. The researchers expect medicinal use to begin within two to three years. The project builds upon the work of Dr. R.H. Richharia, who recognized the potential of rice varieties decades ago.
